Research roundups
What the literature actually says
Cited summaries of the published research on individual compounds, framed strictly for research use. No protocols, no human-use claims.
Abaloparatide: Research Roundup
A PTHrP(1-34) analog with ACTIVE trial fracture data and biased PTH1 receptor signaling. How it differs from teriparatide and what catalog identity requires.
Adamax: Research Roundup
An N-acetylated Semax variant common in research catalogs. Terminal modification chemistry, stability literature, and identity verification vs. parent Semax.
Angiotensin (1-7): Research Roundup
A heptapeptide arm of the renin-angiotensin system studied via Mas receptor signaling. Cardiovascular and fibrosis research within an RUO frame.
AOD-9604: Research Roundup
An hGH fragment analog with lipolytic research interest. What preclinical literature reports — and where the evidence gaps are.
ARA-290: Research Roundup
An EPO-derived nonerythropoietic peptide targeting innate repair receptor signaling. Phase 2 neuropathy data, tissue-protection literature, and RUO identity standards.
Argireline: Research Roundup
A widely used acetyl hexapeptide in cosmetic dermatology research. SNAP-25 mimetic literature, topical studies, and hexapeptide identity standards.
B7-33: Research Roundup
A single-chain relaxin-2 B-chain analog and biased RXFP1 agonist. Anti-fibrotic rodent literature, signaling selectivity, and synthesis identity requirements.
BPC-157: Research Roundup
A pentadecapeptide studied extensively in rodent models. What the preclinical literature reports — and what remains unestablished in humans.
Cagrilintide: Research Roundup
A long-acting amylin analog studied alongside GLP-1 agonists in metabolic research. Mechanism, literature, and quality considerations.
Cartalax: Research Roundup
An Ala-Glu-Asp tripeptide bioregulator discussed in cartilage and connective-tissue aging research. What the Khavinson literature reports — and how it differs from recovery peptides.
CGRP: Research Roundup
A sensory neuropeptide central to migraine pathophysiology and modern drug development. Isoforms, receptor biology, approved therapeutics, and native peptide supply.
CJC-1295 (with DAC): Research Roundup
A long-acting GHRH analog with Drug Affinity Complex modification. Pharmacokinetic research, literature, and documentation notes.
CJC-1295 (no DAC): Research Roundup
The shorter-acting tetrasubstituted GHRH(1-29) analog. How it differs from the DAC form, what literature reports, and COA expectations.
Copper Peptides Beyond GHK-Cu: Research Roundup
A class overview of copper-binding peptides in dermatology and matrix research. How GHK-Cu anchors the literature and what to verify in catalog supply.
Cortagen: Research Roundup
An Ala-Glu-Asp-His tetrapeptide bioregulator studied in adrenal cortex and stress-axis aging research. What the Khavinson literature describes — and how it differs from GH peptides.
Dihexa: Research Roundup
An HGF-mimetic oligopeptide studied for synaptogenesis in rodent cognition models. What the preclinical record reports — and what remains unestablished in humans.
DSIP: Research Roundup
A nine-residue peptide linked to sleep-architecture research since the 1970s. Mixed human and animal data, unsettled mechanism, and what catalog supply requires.
Epithalon: Research Roundup
A synthetic tetrapeptide tied to telomerase and pineal-aging research in the Khavinson bioregulator literature. What preclinical reports describe — and what remains unverified in humans.
Exenatide: Research Roundup
The first-in-class GLP-1 receptor agonist derived from exendin-4. Foundational incretin literature, mechanisms, and material-quality considerations.
FOXO4-DRI: Research Roundup
A D-retro-inverso peptide studied for senescent cell clearance in preclinical models. What the senolytic literature reports — and where human evidence stops.
GHK-Cu (Copper Tripeptide-1): Research Roundup
A naturally occurring copper-binding tripeptide widely studied in dermatology and cosmetic research. What the literature shows and where it ends.
GHRP-2: Research Roundup
A classic growth hormone releasing peptide with decades of GH-axis research. Literature summary, limitations, and material evaluation.
GHRP-6: Research Roundup
A first-generation GHRP widely cited in secretagogue research. GH-axis literature, noted appetite effects in models, and quality checks.
Glutathione: Research Roundup
The central intracellular tripeptide antioxidant. Redox biology, aging research literature, and how to evaluate reduced versus oxidized catalog forms.
Hexarelin: Research Roundup
A potent hexapeptide ghrelin mimetic with GH-axis and cardioprotective research angles in animal models. Evidence and limitations.
Humanin: Research Roundup
A 24-amino-acid mitochondrial peptide first identified in surviving Alzheimer's disease neurons. What cytoprotective and metabolic literature reports — and where clinical evidence ends.
IGF-1 LR3: Research Roundup
A long-acting IGF-1 analog engineered for reduced IGFBP binding. GroPep-era pharmacology, preclinical anabolic literature, and strict identity requirements for an 83-mer.
Ipamorelin: Research Roundup
A selective growth hormone secretagogue studied in GH-axis research. Ghrelin receptor pharmacology, literature, and material quality.
KPV: Research Roundup
A tripeptide fragment of alpha-MSH studied in gut and skin inflammation models. What preclinical literature reports within a research-use-only frame.
Liraglutide: Research Roundup
An acylated GLP-1 receptor agonist with extensive published trial literature. What mechanisms and evidence tiers mean for research-grade material.
LL-37: Research Roundup
The sole human cathelicidin peptide, studied across innate immunity and inflammatory signaling. What the literature reports — and what remains unestablished outside defined models.
Mazdutide: Research Roundup
A dual GLP-1 and glucagon receptor agonist in active clinical development. What published phase 2 literature reports within an RUO frame.
Melanotan II: Research Roundup
A synthetic melanocortin agonist studied in pigmentation and central receptor pharmacology. Literature scope, MC1R context, and material verification.
Mechano Growth Factor (MGF): Research Roundup
The IGF-1Ec splice variant and its synthetic E-peptide — satellite cell literature, naming confusion, and why catalog MGF requires sequence proof.
MOTS-c: Research Roundup
A mitochondrial-derived 16-mer studied for metabolic regulation and exercise-mimetic effects in rodents. What the ORF literature describes — and how synthetic catalog supply differs from endogenous peptide.
N-Acetyl Selank Amidate: Research Roundup
A dual-modified Selank derivative with acetylation and C-terminal amidation. Tuftsin analog context, stability chemistry, and batch identity standards.
N-Acetyl Semax Amidate: Research Roundup
A dual-modified Semax derivative with N-terminal acetylation and C-terminal amidation. Stability chemistry, identity verification, and literature context.
Ovagen: Research Roundup
A Glu-Asp-Leu tetrapeptide bioregulator associated with liver and hepatocyte aging research. What the Khavinson literature reports — and how it differs from antioxidant peptides.
Oxytocin: Research Roundup
A nonapeptide hormone with extensive human research — from obstetric pharmacology to social neuroscience. Evidence tiers, routes of administration, and RUO supply.
P21: Research Roundup
A CNTF-derived synthetic peptide studied for neurogenesis in brain-injury models. Preclinical literature, naming pitfalls, and material verification for research supply.
Palmitoyl Pentapeptide-4: Research Roundup
The Matrixyl lipopeptide studied in collagen-stimulation cosmetic research. Fibroblast literature, palmitoylation chemistry, and lipopeptide QC.
PEG-MGF: Research Roundup
Pegylated synthetic MGF with extended half-life — a non-endogenous construct studied in muscle repair models. Preclinical-only evidence and strict identity requirements.
Pinealon: Research Roundup
A Glu-Asp-Arg tripeptide bioregulator studied in neuroprotective and brain-aging research. What the Khavinson literature describes — and what remains unestablished clinically.
PNC-27: Research Roundup
A synthetic p53-derived peptide studied in preclinical oncology models. What selective cytotoxicity literature reports — and where human evidence ends.
PT-141: Research Roundup
A melanocortin receptor agonist with published phase 3 clinical literature. Central pharmacology, bremelanotide evidence, and catalog material quality.
Retatrutide: Research Roundup
A triple GLP-1/GIP/glucagon receptor agonist in early clinical research. Preclinical context, evidence gaps, and material evaluation.
Selank: Research Roundup
A tuftsin-derived heptapeptide studied in anxiolytic and immunomodulatory models. Russian pharmacology context, literature scope, and material quality.
Semaglutide: Research Roundup
A GLP-1 receptor agonist with extensive published literature. What preclinical and clinical research reports — within an RUO frame.
Semax: Research Roundup
An ACTH(4-10) analog with extensive neuropharmacology literature. Neurotrophin signaling, preclinical models, and catalog identity verification.
Sermorelin: Research Roundup
The GHRH(1-29) analog with decades of formal GH-stimulation research. Pediatric approval history, adult somatotropic literature, and catalog identity concerns.
Snap-8: Research Roundup
An acetylated octapeptide studied in cosmetic neuromuscular signaling research. In vitro literature, formulation science, and material verification.
SS-31: Research Roundup
A mitochondria-targeted tetrapeptide studied in heart failure, mitochondrial myopathy, and rare disease trials. What elamipretide literature reports — and how catalog supply differs from clinical drug product.
Survodutide: Research Roundup
A dual GLP-1/glucagon receptor agonist studied in metabolic and MASH research trials. Phase 2 literature and RUO material considerations.
TB-500 (Thymosin Beta-4 Fragment): Research Roundup
TB-500 is associated with thymosin beta-4 biology. A look at the actin-binding research context and the gaps in human evidence.
Teriparatide: Research Roundup
Recombinant PTH(1-34) — the first widely approved bone anabolic peptide. Fracture trial data, intermittent PTH biology, and why catalog material differs from Forteo.
Tesamorelin: Research Roundup
An FDA-approved GHRH(1-44) analog with published phase 3 human data in HIV-associated lipodystrophy. What the clinical literature reports — and how catalog material differs.
Thymalin: Research Roundup
A thymus-associated peptide bioregulator studied in immune aging and thymic involution research. What the Khavinson literature reports — and why preparation identity matters.
Thymosin Alpha-1: Research Roundup
A 28-amino-acid thymic peptide with decades of immunology research and formal clinical programs in some jurisdictions. What the literature reports within an RUO frame.
Thymosin Beta-4: Research Roundup
The full 43-amino-acid actin-binding protein behind TB-500 fragment commerce. Wound-healing trials, actin sequestration biology, and sequence verification.
Tirzepatide: Research Roundup
A dual GIP/GLP-1 receptor agonist studied in metabolic research. Mechanism context, published evidence, and documentation expectations.
Vesugen: Research Roundup
A Lys-Glu-Asp tripeptide bioregulator studied in vascular and endothelial aging models. What the Khavinson literature describes — and how it relates to cardiovascular research peptides.
VIP: Research Roundup
A 28-residue neuropeptide studied across immunology, circadian biology, and neuroprotection. Receptor pharmacology, literature breadth, and RUO material standards.
Ziconotide: Research Roundup
A cone-snail conopeptide approved as intrathecal analgesic Prialt — and a distinct research catalog entity. Cav2.2 pharmacology, trial evidence, and identity standards.